Reproductive Longevity Therapeutics

Interventions specifically targeting ovarian aging to prolong fertility and delay systemic female aging.
BACK TO EPOCHVIEW INTERACTIVE VERSION
Reproductive Longevity Therapeutics

The ovaries age faster than any other organ, driving systemic aging in women through hormonal loss. These therapies—ranging from mTOR inhibitors to specific ovarian rejuvenation factors—aim to maintain youthful ovarian function, delaying menopause and its associated risks of cardiovascular disease, osteoporosis, and cognitive decline.

TRL
4/9Formative
Impact
5/5
Investment
5/5
Category
Applications

Connections

Applications
Longevity Gene Augmentation

Gene therapy delivering variants of FOXO3, SIRT6, Klotho, and other longevity-associated genes.

TRL
3/9
Impact
5/5
Investment
5/5
Software
Cross-Species Longevity Translation Models

AI systems that translate longevity interventions from model organisms to human therapeutics.

TRL
5/9
Impact
4/5
Investment
4/5
Ethics Security
Ethics Security
Regulatory Classification Challenges

New regulatory categories for interventions that blur the lines between drug, device, and lifestyle.

TRL
2/9
Impact
5/5
Investment
2/5

Envisioning is an emerging technology research institute and advisory.

XLinkedInInstagramWhatsApp

2011 — 2026

services
research
work
about